Wuhan Jingkangen Biomedical Technology Co., Ltd
Firmenname:
Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:
13720134139 +86 -0-15871494362
E-Mail:
orders@jknbiochem.com
Nationalität:
China
URL:
www.jknbiochem.com
Produkte insgesamt:
5792
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
Produktkatalog
Research Grade Bersanlimab
1987854-08-9
Research Grade Iscalimab
2031153-61-2
Research Grade Vopratelimab
2039148-04-2
Research Grade Leronlimab
674782-26-4
Research Grade Ravagalimab
2050816-56-1
Research Grade Lenvervimab
2055006-79-4
Research Grade Abrezekimab
2043952-59-4
Research Grade Etigilimab
2044984-83-8
Sutimlimab
2049079-64-1
Cetrelimab
2050478-92-5
Research Grade Imaprelimab
2014343-04-3
Belantamab
2061894-48-0
Murlentamab
2058047-65-5
Olinvacimab
2095504-49-5
Abelacimab
2098724-83-3
Budigalimab
2098225-93-3
Samrotamab
2052591-32-7
Onvatilimab
1969313-51-6
Research Grade Mitazalimab
2055640-86-1
Research Grade Enapotamab
1912423-61-0
Research Grade Tepoditamab
2044679-53-8
Cemiplimab
1801342-60-8
Dostarlimab
2022215-59-2
Frovocimab
1643672-70-1
Nirsevimab
1989556-22-0
Marstacimab
1985638-39-8
Research Grade Gosuranemab
1788032-39-2
Research Grade Zampilimab
2098280-42-1
Osocimab
2056878-75-0
Research Grade Prolgolimab
2093956-19-3
Research Grade Omburtamab
1895083-75-6
Orilanolimab
2066544-85-0
Sintilimab
2072873-06-2
Tabituximab
1644134-10-0
Rolinsatamab
2095467-30-2
Toripalimab
1924598-82-2
Research Grade Temelimab
1393641-34-3
Gancotamab
1509928-00-0
Mezagitamab
2227490-52-8
Research Grade Mosunetuzumab
1905409-39-3
Sirtratumab
1824663-82-2
Loncastuximab
1875032-68-0
Research Grade Ladiratuzumab
1629760-28-6
Research Grade Atidortoxumab
1939108-95-8
Berlimatoxumab
1939109-24-6
Tiragolumab
1918185-84-8
Research Grade Gimsilumab
1648796-29-5
Ianalumab
1929549-92-7
Zenocutuzumab
1969309-56-5
Research Grade Bemarituzumab
1952272-74-0
Research Grade Prasinezumab
1960462-19-4
Research Grade Iladatuzumab
1906205-76-2
Cofetuzumab
1869928-62-0
Research Grade Tibulizumab
1849636-24-3
Cibisatamab
2101242-53-7
Relatlimab
1673516-98-7
Ontamalimab
2098790-40-8
Netakimab
1796570-08-5
Crovalimab
1917321-26-6
Research Grade Romilkimab
1399584-78-1
Research Grade Cusatuzumab
1399546-01-0
Research Grade Faricimab
1607793-29-2
Azintuxizumab
1826819-57-1
Gedivumab
1807954-17-1
Lesofavumab
1807960-57-1
Flotetuzumab
1664355-28-5
Brazikumab
1610353-18-8
Ranevetmab
1632282-27-9
Sacituzumab
1796566-95-4
Rosmantuzumab
1684393-04-1
Losatuxizumab
1801544-27-3
Varisacumab
1610010-60-0
Letolizumab
1450981-87-9
Suvratoxumab
1629620-18-3
Frunevetmab
1708936-80-4
Garetosmab
2097125-54-5
Tomaralimab
1449294-76-1
Maftivimab
2135632-36-7
Crizanlizumab
1690318-25-2
Emapalumab
1709815-23-5
Aprutumab
1634620-63-5
Camrelizumab
1798286-48-2
Vunakizumab
1792181-33-9
Utomilumab
1417318-27-4
Telisotuzumab
1781223-80-0
Dezamizumab
1662664-56-3
Lutikizumab
1791411-57-8
Research Grade Zanidatamab
2169946-15-8
Research Grade Zolbetuximab
1496553-00-4
Porgaviximab
1792982-55-8
Lacnotuzumab
1831128-32-5
Tomuzotuximab
1646321-00-7
alacotuzumab
1826831-79-1
Selicrelumab
1622140-49-1
Larcaviximab
1792982-56-9
Gilvetmab
1808081-43-7
Timigutuzumab
1665274-14-5
Oleclumab
1803176-05-7
Cosfroviximab
1792982-57-0
Gatipotuzumab
1264737-26-9
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
Copyright 2019 © ChemicalBook. All rights reserved